Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
7.13
-0.32 (-4.32%)
At close: May 12, 2025, 4:00 PM
7.82
+0.69 (9.71%)
After-hours: May 12, 2025, 7:45 PM EDT
Company Description
Liminatus Pharma, LLC operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
Liminatus Pharma, Inc.
| Country | United States |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Chris Kim |
Contact Details
Address: 6 Centerpointe Drive, #625 LA Palma, California 90623 United States |
Stock Details
| Ticker Symbol | LIMN |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001831874 |
Key Executives
| Name | Position |
|---|---|
| Chris Kim J.D., L.L.M. | Chief Executive Officer, Treasurer and Secretary |